Perspectives for the new peptide millennium
George Barany and Gregg Fields (Overview): When we were discussing an appropriate
way to bring this Symposium to an exciting scientific conclusion, we recognized that the …
way to bring this Symposium to an exciting scientific conclusion, we recognized that the …
[BOOK][B] Peptides for the New Millennium: Proceedings of the 16th American Peptide Symposium June 26–July 1, 1999, Minneapolis, Minnesota, USA
… The fortunate coincidence of the calendar allowed us to set as the theme " Peptides for
the New Millennium", and in our judgment, the approximately 1200 participants [2] who …
the New Millennium", and in our judgment, the approximately 1200 participants [2] who …
Peptides for the New Millennium [electronic resource]: Proceedings of the 16th American Peptide Symposium June 26–July 1, 1999, Minneapolis, Minnesota, USA
… The fortunate coincidence of the calendar allowed us to set as the theme “Peptides for the
New Millennium”, and in our judgment, the approximately 1200 participants [2] who converged …
New Millennium”, and in our judgment, the approximately 1200 participants [2] who converged …
Bradykinin antagonists: Anti-cancer drugs for the new millennium?
JM Stewart, L Gera, EJ York, DC Chan… - … for the New Millennium …, 2002 - Springer
Conquest of cancer is a major goal for the new millennium. Although much emphasis is
currently being placed on genetic manipulation for development of new anti-cancer drugs, more …
currently being placed on genetic manipulation for development of new anti-cancer drugs, more …
The a-factor lipopeptide pheromone ofSaccharomyces cerevisiae: Synthesis, bioactivity, and biophysical analyses of
H Xie, JM Becker, F Naider - Peptides for the New Millennium - Springer
Sexual reproduction in the yeast Saccharomyces cerevisiae is triggered by a reciprocal
exchange of pheromones, termed α-factor and a-factor. The farnesylated C-terminal …
exchange of pheromones, termed α-factor and a-factor. The farnesylated C-terminal …
The design and synthesis of non-peptide somatostatin receptor agonists
L Yang, Y Pan, L Guo, G Morriello, A Pasternak… - … for the New Millennium …, 2002 - Springer
Conclusion In summary, we have demonstrated that highly potent and selective agonist can
be obtained by derivatizing (2R, 3S)-2-Me-Trp-LysOtBu with a variety of privileged structures …
be obtained by derivatizing (2R, 3S)-2-Me-Trp-LysOtBu with a variety of privileged structures …
Post-translational modification: A two-dimensional strategy for molecular diversity of Conus peptides
D Hooper, MB Lirazan, R Schoenfeld, B Cook… - … for the New Millennium …, 2002 - Springer
The venomous cone snails (Conus), arguably the largest living genus of marine animals (ca.
500 species), use venom for capturing prey, defense and other purposes [1]. The venoms …
500 species), use venom for capturing prey, defense and other purposes [1]. The venoms …
Stimulation and suppression of the immune response and hemopoiesis by novel natural and synthetic peptides
VI Deigin, AM Poverenny, OV Semina… - … for the New Millennium …, 2002 - Springer
A new approach has been created for design and development of potent peptide preparations
for precise regulation (stimulation as well as suppression) of the immune system. Initially …
for precise regulation (stimulation as well as suppression) of the immune system. Initially …
New dimensions in the design of potent and receptor selective melanotropin analogs
P Grieco, G Han, VJ Hruby - Peptides for the New Millennium …, 2002 - Springer
Design of potent and selective ligands for the melanocortin receptors (MCRs) based on
MSH has recently been vigorously pursued in our laboratory. Historically, the core structure (also …
MSH has recently been vigorously pursued in our laboratory. Historically, the core structure (also …
Strategies for the synthesis of labeled peptides
L Bibbs, NP Ambulos, SA Kates, A Khatri… - … for the New Millennium …, 2002 - Springer
The ABRF Peptide Synthesis Research Group (PSRG) conducts annual studies in order to
assist member laboratories in assessing their peptide synthetic capability [1]. Concurrently, …
assist member laboratories in assessing their peptide synthetic capability [1]. Concurrently, …